Literature DB >> 1417084

Clinical significance of mucin production in post-irradiated cervical carcinoma.

N Y Cheung1, R J Collins, H Y Ngan, L C Wong, H K Ma.   

Abstract

Histological sections from 50 patients with clinical stage Ib to stage IIb squamous cell carcinoma of the cervix, initially treated by radiotherapy and followed by Wertheim hysterectomy, were reviewed and stained for mucin. The tissues from 17 (34%) of the patients contained no residual carcinoma. Mucin production was demonstrated in tumour tissue from 18 (55%) of the patients with residual tumour, none of who died of disease during the 5 to 10 years of follow up. Two patients who died of recurrent carcinoma had no mucin production in the post-irradiated tumour tissues. The presence of mucin in irradiated carcinoma of cervix seems to infer a better prognosis and this may prove useful in the follow-up of irradiated carcinomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417084     DOI: 10.1007/bf02389599

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  Survival in cervical cancer with respect to cell type.

Authors:  W B WENTZ; J W REAGAN
Journal:  Cancer       Date:  1959 Mar-Apr       Impact factor: 6.860

2.  Incidence, histology, and response to radiation of mixed carcinomas (adenoacanthomas) of the uterine cervix.

Authors:  C P CHERRY; A GLUCKSMANN
Journal:  Cancer       Date:  1956 Sep-Oct       Impact factor: 6.860

3.  A clinical-pathological correlation of cell type classification for cervical cancer.

Authors:  D S Swan; J W Roddick
Journal:  Am J Obstet Gynecol       Date:  1973-07-01       Impact factor: 8.661

4.  Histologic classification, lymph node metastases, and patient survival in stage IB cervical carcinoma: an analysis of 245 uniformly treated cases.

Authors:  J B Beecham; T Halvorsen; A Kolbenstvedt
Journal:  Gynecol Oncol       Date:  1978-02       Impact factor: 5.482

5.  Prognostic factors in stage I Carcinoma of the cervix.

Authors:  J Boyce; R G Fruchter; A D Nicastri; P C Ambiavagar; M S Reinis; J H Nelson
Journal:  Gynecol Oncol       Date:  1981-10       Impact factor: 5.482

6.  Carcinoma of the cervix: an attempt to individualize treatment. Results of a 20-year cooperative study.

Authors:  J Zander; J Baltzer; K J Lohe; K G Ober; C Kaufmann
Journal:  Am J Obstet Gynecol       Date:  1981-04-01       Impact factor: 8.661

7.  Mucin production in defining mixed carcinoma of the uterine cervix: a clinicopathologic study.

Authors:  J A Benda; C E Platz; H Buchsbaum; S Lifshitz
Journal:  Int J Gynecol Pathol       Date:  1985       Impact factor: 2.762

8.  Identification of histopathologic risk groups in stage IB squamous cell carcinoma of the cervix.

Authors:  P Gauthier; I Gore; H M Shingleton; S J Soong; J W Orr; K D Hatch
Journal:  Obstet Gynecol       Date:  1985-10       Impact factor: 7.661

9.  Prognostic significance of parametrial extension in patients with cervical carcinoma Stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation.

Authors:  T Inoue; M Okumura
Journal:  Cancer       Date:  1984-10-15       Impact factor: 6.860

10.  Prognostic factors and operative treatment of stages IB to IIB cervical cancer.

Authors:  E Burghardt; H Pickel; J Haas; M Lahousen
Journal:  Am J Obstet Gynecol       Date:  1987-04       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.